MBRX 8-K 2026-10-30

Moleculin Biotech, Inc. (MBRX) 8-K dated 2026-10-30 — accession 0001437749-26-034075.

Moleculin Biotech, Inc. (MBRX) is a biotechnology company listed on US.

Moleculin Biotech, Inc. filed a 8-K on 2026-10-30. Accession 0001437749-26-034075.

This 8-K covers: Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported MBRX revenue for 2025-12-31 was $0. Net income was -$33.6M. MBRX currently screens at market cap $8.2M.

Not investment advice. The MBRX SEC hub lists recent forms. The stock page is the research view.